David Shaw’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$547K Buy
+22,500
New +$622K ﹤0.01% 4194

Other funds holding NAMS

David Shaw's NAMS Position: Q3 2026 in Review

David Shaw sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 120,561 shares — an estimated $3.33M sold.

David Shaw first reported a position in NAMS in Q3 2024 and held it in 2 quarters. The position peaked at $4.09M in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • David Shaw reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
  • David Shaw sold 120,561 NewAmsterdam Pharma shares in Q3 2026, an estimated $3.33M.
  • David Shaw first reported a position in NewAmsterdam Pharma in Q3 2024 and held it in 2 quarters.
  • David Shaw's NewAmsterdam Pharma position peaked at $4.09M in Q2 2026.
  • 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.